Becton Dickinson (BDX) Shares Outperform with 1.13 Gain as $290M Volume Ranks 389th in U.S. Equity Market

On Sept. 11, 2025, Becton Dickinson (BDX) traded with a volume of $290 million, ranking 389th among U.S. equities. , outperforming broader market benchmarks.

Recent market commentary highlighted the company’s competitive positioning in medical technology innovation, with analysts noting sustained demand for its diagnostic solutions. Institutional investors increased exposure to the name, reflecting confidence in its long-term growth trajectory.

Technical indicators showed positive momentum across multiple timeframes, . Options market data revealed a shift in positioning toward bullish strategies, .

To run this back-test properly I'll need a bit more detail: 1. Market universe - should I rank all U.S. listed stocks each day, or only a specific index/segment (e.g. S&P 500 constituents, NASDAQ, NYSE, etc.)? 2. Portfolio construction - equal-weight the 500 names each day, or weight by something else? 3. Trade prices - enter at next day's open and exit at that day's close, or enter at today's close and exit at tomorrow's close? 4. Slippage / transaction costs - assume zero, or apply a specific amount? Once I have these clarifications I can generate the data-gathering plan and start the back-test.